Related Experiment Video
Updated: Jun 16, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Thrombolysis during the endovascular treatment of iliac artery occlusions
Giuseppe Taddei1, Paolo Tamellini, Faccioli Niccolo
1Department of Radiology, Sacro Cuore Hospital, Negrar, Italy.
Insights
Thrombolysis before percutaneous treatment significantly improves recanalization rates for iliac occlusions. This approach enhances the success of angioplasty and stenting in patients with claudication.
Area of Science:
- Vascular Surgery
- Interventional Radiology
- Cardiovascular Medicine
Background:
- Iliac occlusions often lead to debilitating claudication.
- Percutaneous treatments are standard, but challenging in occlusive disease.
Purpose of the Study:
- To evaluate the therapeutic benefit of thrombolysis before angioplasty and stenting for iliac occlusions.
- To determine if pre-procedural thrombolysis improves outcomes in iliac artery recanalization.
Main Methods:
- Retrospective analysis of 28 iliac occlusion cases in 26 patients over six years.
- Thrombolysis using urokinase-type plasminogen activator administered for an average of 28.2 hours.
- Follow-up averaged 46.6 months to assess long-term outcomes.
Main Results:
- Successful guidewire passage and thrombolysis achieved in 84% (21/25) of cases.
- Complete thrombus dissolution and iliac axis recanalization occurred in all successfully treated cases.
- 95% (20/21) of cases with complete thrombolysis proceeded to successful percutaneous treatment.
Conclusions:
- Pre-procedural thrombolysis offers a potential advantage in treating atherosclerotic iliac artery occlusions.
- This strategy may enhance the efficacy of subsequent percutaneous interventions like angioplasty and stenting.
Purpose:
The purpose of this study was to assess the possible therapeutic advantage of thrombolysis prior to recanalization of iliac occlusions with percutaneous treatment angioplasty and stenting.
Materials And Methods:
We retrospectively studied 28 cases of iliac occlusions in 26 patients, occurring over a six-year period. All patients suffered from claudication. Percutaneous treatments were performed using thrombolysis in 25 cases. The average duration of the infusion with urokinase-type plasminogen activator was 28.2 hours (range, 9-48 hours); total dose was 1,820,000 units per hour. The average duration of the follow-up was 46.6 months (range, 2-81 months).
Results:
In 21 of 25 cases (84%), we managed to correctly pass through the iliac occlusion using a guidewire and completed the thrombolysis. In all these cases, thrombolysis caused the complete dissolution of thrombi. All 21 cases with complete thrombolytic treatment had complete recanalization of the iliac axis. Twenty of these 21 cases (95%) were than successfully treated with percutaneous methodologies.
Conclusion:
Thrombolysis may give an advantage in approaching the percutaneous treatment of atherosclerotic iliac arterial occlusions.
More Related Videos
07:50An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
Published on: June 4, 2021
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Peripheral Artery Disease III: Interprofessional Care
Clot Retraction and Fibrinolysis
Venous Thrombosis I: Introduction